Risk factors for development and mortality of invasive pulmonary Aspergillosis in kidney transplantation recipients

[1]  R. Matesanz,et al.  Global Organ Transplant Activities in 2015. Data from the Global Observatory on Donation and Transplantation (GODT) , 2017 .

[2]  O. Manuel,et al.  Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  J. Fishman Infection in Organ Transplantation , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  O. Manuel,et al.  Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  D. Denning,et al.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Nucci,et al.  Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case–Control Study , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  P. Martín-Dávila,et al.  Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients. , 2016, The Journal of infection.

[8]  B. Ener,et al.  Invasive Fungal Infections in Renal Transplant Recipients: Epidemiology and Risk Factors , 2015, Mycopathologia.

[9]  B. Bammens,et al.  Invasive aspergillosis after kidney transplant: case-control study. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  A. Moreno,et al.  Epidemiology, clinical characteristics, and outcome of invasive aspergillosis in renal transplant patients , 2014, Transplant infectious disease : an official journal of the Transplantation Society.

[11]  J. Pascual,et al.  Invasive aspergillosis in kidney transplant recipients: a cohort study. , 2014, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

[12]  Y. S. Kim,et al.  Initial report of the Korean Organ Transplant Registry: the first report of national kidney transplantation data. , 2014, Transplantation proceedings.

[13]  Gang Huang,et al.  Efficacy and safety of thymoglobulin and basiliximab in kidney transplant patients at high risk for acute rejection and delayed graft function. , 2013, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

[14]  J. Rello,et al.  A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. , 2012, American journal of respiratory and critical care medicine.

[15]  M. Bodro,et al.  Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients. , 2012, Transplantation proceedings.

[16]  D. Brennan,et al.  Delayed Graft Function in the Kidney Transplant , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  E. Anaissie,et al.  Factors associated with mortality in transplant patients with invasive aspergillosis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  Hojoong Kim,et al.  Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[19]  E. Anaissie,et al.  Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  Philippe Lutun,et al.  Factors associated with overall and attributable mortality in invasive aspergillosis. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  A. Garg,et al.  Marked variation in the definition and diagnosis of delayed graft function: a systematic review. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  J. Perfect,et al.  Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  B. Barlogie,et al.  Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  M. Boeckh,et al.  Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  A. Alborzi,et al.  Fungal infections in solid organ recipients. , 2005, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

[26]  P. Grossi,et al.  Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. , 2000, Transplantation.

[27]  R. Pinner,et al.  The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  J. Tayek,et al.  Weight loss and diabetes are new risk factors for the development of invasive aspergillosis infection in non-immunocompromized humans. , 2017, Clinical practice.

[29]  S. Kim,et al.  Invasive pulmonary aspergillosis after solid organ transplantation: diagnosis and treatment based on 28 years of transplantation experience. , 2009, Transplantation proceedings.

[30]  B. Einollahi,et al.  Invasive fungal infections following renal transplantation: a review of 2410 recipients. , 2008, Annals of transplantation.

[31]  J. Chapman,et al.  International Journal of Organ Transplantation Medicine , 2022 .